Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Lutetium-177

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SHINE, C-Ray Therapeutics Partner For Lu-177 Supply In China
    SHINE, C-Ray Therapeutics Partner For Lu-177 Supply In China

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/shine-and-c-ray-therapeutics-establish-strategic-partnership-for-exclusive-distribution-of-non-carrier-added-lu-177-in-mainland-china-302725516.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share
    ProstACT Global Ph 3 Study (Part 1) Achieves Primary Objectives
    ProstACT Global Ph 3 Study (Part 1) Achieves Primary Objectives

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3252392/0/en/ProstACT-Global-Phase-3-Study-Part-1-Achieves-Primary-Objectives.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Curium, PeptiDream Enroll 1st Patient in Lu-PSMA-I&T Trial Japan
    Curium, PeptiDream Enroll 1st Patient in Lu-PSMA-I&T Trial Japan

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231755/0/en/Curium-Group-PeptiDream-and-PDRadiopharma-Enroll-First-Patient-to-Registrational-Clinical-Trial-of-Lu-PSMA-I-T-for-Prostate-Cancer-in-Japan.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    UK's First Patients to Receive Doses of Blue Earth Lutetium-177Lu
    UK's First Patients to Receive Doses of Blue Earth Lutetium-177Lu

    15 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/first-patients-in-the-uk-receive-doses-of-blue-earth-therapeutics-investigational-radiopharmaceutical-therapy-lutetium-177lu-rhpsma-10-1-injection-for-metastatic-castrate-resistant-prostate-cancer-302661434.html

    PR NEWSWIRE
    15 Jan 2026
    Share Share
    Nusano, Ariceum Therapeutics Ink Multi-Isotope Supply Deal
    Nusano, Ariceum Therapeutics Ink Multi-Isotope Supply Deal

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166030/0/en/Nusano-and-Ariceum-Therapeutics-Announce-Multi-Isotope-Supply-Agreement.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    C-Ray Backs Mednovo Ph 3 Trial, First Patient Dosed With 177Lu
    C-Ray Backs Mednovo Ph 3 Trial, First Patient Dosed With 177Lu

    10 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/c-ray-therapeutics-supports-mednovos-phase-iii-clinical-trial-with-first-patient-dosed-for-lutetium-177lu-oxodotreotide-injection-302552536.html

    PR NEWSWIRE
    10 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.